CHC

  • About Us
  • News
  • Coming Up
  • Resources
  • Contact Us
  • Search

DTC and Medical Marketing — Tax Issues

July 17, 2009

From DTC Perspectives:

expository essay

Representatives John Fleming and Frank Pallone set Erin Burnett of CNBC straight on the value of DTC and why removing its tax deductibility is not a good idea.

View the article on their website

Posted in DTC Advertising, Legislative

Post navigation

The DTC Fight Is Far From Over
Coalition Asks Senate to Focus on Patient Access to Care

Categories

  • CHC News
  • Courts/First Amendment
  • Data Privacy
  • Drug Pricing
  • DTC Advertising
  • General
  • Legislative
  • Off-label Promotion
  • Point of Care
  • Regulatory/FDA
  • Uncategorized
  • Washington Focus

Recent Posts

  • User Fee Legislation Markup Suggests Added FDA Regulatory Authorities
  • Clinical Trials Not Sufficiently Diverse – and Diversity Data Often Not Reported
  • Medicare Advantage Plans May Promise More but Deliver Less
  • IQVIA Drug Spending Report: OOP Costs Increasing, but Net Prices Rising Below Inflation
  • Presentation of Risks in DTC Video, HCP Webpage Yields Enforcement Letter for Bausch Health

Tags

ad tax Advertising Coalition CDER CMS coalition for healthcare communication conflict of interest Congress COVID-19 data privacy DDMAC drug prices in DTC ads drug pricing DTC DTC advertising DTC advertising FDA FDA Commissioner FDA Draft Guidance FDA enforcement FDA social media free speech gifts to physicians HHS John Kamp Jon Bigelow kamp Kate Rawson legislation litigation marketing off-label off-label communication omission of risk OPDP OPDP enforcement PhRMA regulation Risk Information rx data Scott Gottlieb social media sunshine act Untitled Letter Warning Letter Wayne Pines
CHC

Smart Brief
© 2021 Coalition for Healthcare Communication. All rights reserved.